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1. Urinary tract infections and the related concerns
Urinary tract infections (UTIs), the second-ranked infectious diseases, are recognized as a big con-
cern relating to global healthcare systems. The problem with UTIs is two-dimensional. From the 
economic aspect, patients with UTIs cost millions of US dollars (USD) for different governments 
annually. From the other dimension, there is a huge number of patients with UTIs which must 
be visited by a considerable number of physicians and specialists that involve an abundance of 
human resources in the public healthcare systems. So, the UTIs should be diagnosed and treated 
definitely at the earliest to decrease the costs and traffics in public healthcare systems [1–6].
Moreover, UTIs are known as multi-microbial infectious diseases, which can be happened 
by bacteria (Gram-positive and/or Gram-negative strains) and fungi. Among Gram-negative 
bacteria, the member of Enterobacteriaceae and, in particular, Escherichia coli and Klebsiella 
pneumoniae are the most common uropathogenic bacterial agents, which may cause different 
types of UTIs. Furthermore, Gram-negative bacteria, including Streptococci, Staphylococci, and 
Enterococci, are involved in UTIs in humans. On the other hand, fungi and particularly Candida 
albicans (C. albicans) strains may act as opportunistic pathogenic fungi for causing UTIs. 
However, the non-C. albicans Candida (NACA) such as C. glabrata and C. tropicalis are reported 
from some countries as the predominant species of the causative agents of UTIs [1, 2, 4, 7–14].
2. Urinary tract infections and diagnostics
Fortunately, the methodologies and procedures of diagnostics are in progress, and the use 
of molecular techniques (e.g., polymerase chain reaction (PCR)) and advanced pan-genomic 
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tools (e.g., microarray technology) help us to have accurate, sharp, reliable, and rapid detec-
tion and identification. Of course, it should be noticed that there is a close relationship between 
the number of specimens and the applied methodology. In other words, the application of 
PCR is useful for limited samples, while the microarray technology is a suitable choice when 
the number of specimens is huge. Thus, the methodologies of diagnosis and treatment should 
be carefully selected for accurate and definite detection to reduce the number of patients with 
UTIs [1, 2, 9, 11, 15, 16].
In recent years among several difficulties with UTIs, another problem has risen up quickly; 
the problem is the appearance of a diversity of antimicrobial-resistant pathogens. A typical 
example for this challenge is the presence of a wide range of extended spectrum ß-lactamases 
(ESBLs) producing bacteria and, in particular, ESBLs producing Enterobacteriaceae. Although 
there are several groups of ESBLs producing bacteria in the family of Enterobacteriaceae, 
uropathogenic Escherichia coli (UPEC) and uropathogenic Klebsiella pneumoniae (UPKP) 
pathotypes are considered as important members, which are able to produce a variety of 
ESBLs [12, 17, 18].
3. The types of urinary tract infections
There are different types of UTIs including acute and/or chronic, asymptomatic and/or symp-
tomatic (mild/moderate and/or severe), complicated and/or uncomplicated, and community 
and/or nosocomial acquired infections. If the UTIs occur ≥ three times in a year or ≥ two 
times continuously after disappearance (treatment) of the first infection in a half year, they 
are recognized as recurrent UTIs (rUTIs). In addition to this diversity, as the human’s urinary 
tract (UT) is divided into two parts of lower and upper sections, the UTIs may occur in the 
lower part of the UT (known as cystitis) and/or upper part of the UT (known as nephritis). 
These characteristics are in association with microbial pathogenomics, duration of infection, 
and the abilities of human host. The threshold of microbial population for UTIs is reported 
as ≥100,000 living cells or colony-forming unit (CFU) per urine milliliter (ml); however, it 
varies from 100 to 1000 to 100,000 CFU/ml. Of course, the UTIs without syndromes and with 
syndromes are recognized as asymptomatic and symptomatic UTIs, respectively [1, 2, 4, 7–10, 
12, 19–22].
4. Predisposing factors relating to urinary tract infections
There are a wide range of predisposing factors, which determine the rate of UTIs among 
human populations. Age, gender, pregnancy, sexual activities, multi-sexual partners, urina-
tion, personal hygiene, nutrition regime, application of spermicide devices and diaphragm, 
the presence or absence of vaginal Lactobacilli, catheterization, hospitalization, and microbial 
pathogenome and virulome are the most common factors that are involved in UTIs [1, 4, 7, 8, 
12, 20, 21, 23, 24].
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Generally, UTIs are appeared in women ≥18 years old; however, UTIs are recognized in chil-
dren (girls and boys) and men. In accordance with previous reports, >30% of young women 
with the age of 24–26 have experienced at least once a diagnosed UTI. Besides, the rUTIs 
are common among both young and old women with different etiologies. In young women, 
several sexual intercourses, application of spermicidal devices, and different sexual partners 
increase the occurrence of rUTIs, while in old women, the lack of vaginal Lactobacilli popula-
tions, reduction of female hormones, catheterization, and UT surgeries are the most common 
causes of rUTIs. The patients susceptible to rUTIs are suggested to consume antibiotics as a 
proper prophylactic method. Besides, the use of some nutrients like cranberry may prevent 
or reduce the incidence of UTIs and particularly rUTIs in some cases. Interestingly, the rate of 
asymptomatic or symptomatic bacteriuria increases in both old men and women. But, several 
studies show that generally the untreated asymptomatic bacteriuria in pregnant women may 
lead to symptomatic, severe UTIs and even urosepsis. So, treatment of asymptomatic bacteri-
uria in pregnant women is a must [5, 21–23, 25–27].
Hospitalization is one of the significant factors associated with UTIs which results in 
secondary bacteremia. Normally, hospitalization and catheterization are important pre-
disposed factors to nosocomial UTIs because the use of catheters (e.g., bladder catheter) 
may occur during hospitalization which results in UTIs. In parallel with catheterization, 
the problem of biofilm formation within catheters and the presence of multidrug-resistant 
pathotypes relating to microbial causative agents (e.g., ESBLs producing Enterobacteriaceae) 
considerably increase the rate of morbidity and mortality among patients with UTIs. E. coli 
and ESBLs producing E. coli are the pioneers of bacterial causative agents of nosocomial 
UTIs. In addition to bacterial pathogens, the presence of fungal populations and in particu-
lar Candida spp. must be considered as an important threat for progression of nosocomial 
UTIs among catheterized patients; hence, the catheters may act as an important source 
for aggregation of microbial pathogens, which are both antibiotic sensitive and antibiotic 
resistant. Thus, the use of assays pertaining to antibiotic susceptibilities and broad-spec-
trum antibiotics are pivotal items to reduce the number of patients with nosocomial UTIs 
[6, 24, 28].
Microbial pathogenome and virulome are significant factors, which determine the severity of 
UTIs. UPEC, UPKP, Proteus spp., Pseudomonas aeruginosa, Enterococcus spp., and other micro-
bial pathotypes are able to occur in different types of UTIs in their human hosts. Some of 
microbial virulence genes are located on plasmids, while the others are situated on chromo-
somes. So, the presence or absence of microbial virulence genes affects directly on pathogen 
virulencity and pathogenicity [1, 2, 4, 12, 14].
Genetic risk factors (e.g., blood group and stone formation) and diseases (hypertension), 
diabetes, strength of host’s immune system, immune deficiency syndromes (e.g., AIDS), 
immunocompromised patients, spinal cord injuries, etc. are other predisposing factors, which 
increase the incidence of UTIs among human populations [4, 7, 8, 10, 13, 24].
In this book, which consisted of six chapters, the readers will obtain valuable information 
regarding UTIs and the related predisposing factors.
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In Chapter 2, Sorwer Alam Parvez and Dolilur Rahman explain different important viru-
lence factors of UPEC. In this chapter, a wide range of virulence factors pertaining to UPEC 
are mentioned and discussed. Readers may gain valuable information regarding UPEC 
virulome.
In Chapter 3, Mahabubul Islam Majumder, Saleh Ahmed, Ashiqur Rahman Khan, and 
Tarek Ahmed discuss about microorganisms in catheter-associated urinary tract infection 
(CAUTI). Because of the importance of the topic in UTIs, the authors have focused on the 
items which are pivotal to CAUTI and give effective and reliable information regarding the 
field.
In Chapter 4, Ajay Kumar Prajapati clearly represents the importance of diabetes as a sig-
nificant predisposing factor for UTIs. So, the readers who are interested in UTIs relating to 
diabetes will obtain brilliant information regarding the subject.
In Chapter 5, Charalampos Konstantinidis and Achilleas Karafotias have a deep look into 
UTIs in neuro-patients. Today, there are many efforts to find out the solutions regarding 
neuro-patients with UTIs. I believe that the authors of this chapter represent considerable 
information in regard to this topic.
In Chapter 6, Elena Zaitseva, Elena Melnikova, Andrey Shadrin, Valentina Luchaninova, and 
Tatyana Komenkova clearly explain the importance of uropathogenic Enterococcus faecalis 
strains in pediatric UTIs. Moreover, the phenotypic and genetic diversity of the pathotypes is 
discussed and represented. The authors represent a valuable information in association with 
pediatric UTIs caused by uropathogenic E. faecalis.
I hope that this book offers practical information to the readers.
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